
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
Keywords: urinary bladder neoplasms; randomized controlled trials; radiotherapy; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; IDMC; Independent Data Monitoring Committee; MMC; mitomycin C; MRC; Medical Research Council; QLQ; quality of life questionnaire;